COMPARISON OF MEAN GLYCATED HEMOGLOBIN (HBA1C) IN TYPE 2 DIABETIC HEPATITIS C (HCV) PATIENTS WITH SVR ACHIEVED VERSUS SVR NOT ACHIEVED FOLLOWING DIRECT ACTING ANTIVIRALS (DAAS) THERAPY. The Research of Medical Science Review, [S. l.], v. 3, n. 6, p. 94–100, 2025. Disponível em: https://www.thermsr.com/index.php/Journal/article/view/1284.. Acesso em: 24 jun. 2025.